Envía por correo este artículo 
Nefropatía inducida por contraste. Un caso clínico
Resumen
La nefropatía inducida por contraste (NIC) es una complicación derivada de procedimientos en el ámbito hospitalario, caracterizada por el deterioro agudo o subagudo de la función renal debido a la exposición a un medio de contraste yodado.
Para su diagnóstico se requiere el aumento de 0,5 mg/dl o del 25% posterior a la administración de contraste en comparación a la medición de creatinina sérica pre procedimiento.
Los factores de riesgos dependen de aquellos propios de pacientes y aquellos externos a él. El desarrollo de NIC aumenta la morbimortalidad, días de hospitalización y subsecuentemente gastos para el paciente que la desarrolla.
Se han experimentado una gran cantidad de estrategias preventivas, como son el manitol, furosemida, dopamina y la N-Acetilcisteina, sin embargo, no son alentadoras y algunos no concluyentes según estudios, con el propósito de reducir la carga en términos de morbilidad y mortalidad. Mas sin embargo la evidencia actual soporta el uso de la infusión intravenosa de solución salina a 0,9% antes y después del uso de medio de contraste en dosis ya establecidas.
Palabras clave
Referencias
Dangas, Iakovou, Nikolsky, Aymong, Mintz, Kipshidze, Lansky, Moussa, Stone, Moses, Leon, & Mehran. (2006). Radiocontrast-induced acute renal failure—impact beyond the acute phase: Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J cardiol 95: 13-19, 2005. Journal of the American Society of Nephrology: JASN, 17(3), 595–599.
Lindsay, J., Canos, D. A., Apple, S., Pinnow, E., Aggrey, G. K., & Pichard, A. D. (2004). Causes of acute renal dysfunction after percutaneous coronary intervention and comparison of late mortality rates with postprocedure rise of creatine kinase-MB versus rise of serum creatinine. The American Journal of Cardiology, 94(6), 786–789.
Azzalini, L., Poletti, E., Lombardo, F., Laricchia, A., Beneduce, A., Moscardelli, S., Bellini, B., Maccagni, D., Cappelletti, A., Ancona, M. B., Carlino, M., Chieffo, A., Colombo, A., & Montorfano, M. (2019). Risk of contrast-induced nephropathy in patients undergoing complex percutaneous coronary intervention. International Journal of Cardiology, 290, 59–63.
Seeliger, E., Sendeski, M., Rihal, C. S., & Persson, P. B. (2012). Contrast-induced kidney injury: mechanisms, risk factors, and prevention. European Heart Journal, 33(16), 2007–2015.
Marenzi, G., Assanelli, E., Campodonico, J., Marana, I., Metrio, M. D., & Moltrasio, M. (2009). Contrast volume during primary percutaneus coronary intervention and subsequent contrast induced nephropathy and mortality. Ann Intern Med, 150, 170–177.
Mehran, R., Aymong, E. D., Nikolsky, E., Lasic, Z., Iakovou, I., Fahy, M., Mintz, G. S., Lansky, A. J., Moses, J. W., Stone, G. W., Leon, M. B., & Dangas, G. (2004). A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. Journal of the American College of Cardiology, 44(7), 1393–1399.
Cohen, R. M. R. B. J. S., Goldfarb, R. M., S, Winther, S., Svensson, M., Jørgensen, H. S., Birn, H., Bøtker, H. E., & Ivarsen, P. (1994). Nephrotoxic risks of renal angiography: Contrast-media associated nephrotoxicity and atheroembolism A critical review. Am J Kidney Dis, 24(713).
McCullough, P. A., Wolyn, R., & Rocher, L. L. (1997). Acute renal failure after coronary intervention: Incidence, risk factors. and relationship to mortality. Am J Med, 103(368).
Rihal, C. S. T. S. C., & Grill, D. E. (2002). Incidence and prog-nostic importance of acute renal failure after percutaneous coronary intervention. Circulation, 105(2259).
Li, Y., Liu, Y., Fu, L., Mei, C., & Dai, B. (2012). Efficacy of short-term high-dose statin in preventing contrast-induced nephropathy: a meta-analysis of seven randomized controlled trials. PloS One, 7(4), e34450.
Quintavalle, C., Fiore, D., & De Micco, F. (2013). Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury. Journal of Vascular Surgery, 57(3), 892.
Marenzi, Giancarlo, Ferrari, C., Marana, I., Assanelli, E., De Metrio, M., Teruzzi, G., Veglia, F., Fabbiocchi, F., Montorsi, P., & Bartorelli, A. L. (2012). Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial. JACC. Cardiovascular Interventions, 5(1), 90–97.
Yamashita, K., Igawa, W., Ono, M., Kido, T., Okabe, T., Yamamoto, M. H., Amemiya, K., Isomura, N., Araki, H., & Ochiai, M. (2018). Safety and efficacy of tolvaptan for the prevention of contrast-induced acute kidney injury in patients with heart failure and chronic kidney disease. Kidney Diseases (Basel, Switzerland), 5(2), 1–7.
Hainfeld, J. F., Slatkin, D. N., Focella, T. M., & Smilowitz, H. M. (2006). Gold nanoparticles: a new X-ray contrast agent. The British Journal of Radiology, 79(939), 248–253.
Bennett, M., Dent, C. L., Ma, Q., Dastrala, S., Grenier, F., Workman, R., Syed, H., Ali, S., Barasch, J., & Devarajan, P. (2008). Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clinical Journal of the American Society of Nephrology: CJASN, 3(3), 665–673
Er, F., Nia, A. M., & Dopp, H. (2013). Ischemic preconditioning for prevention of contrast medium-induced nephropathy: Randomized pilot RenPro trial (renal protection trial). Journal of Vascular Surgery, 57(2), 601.
Volarevic, V., Djokovic, B., Jankovic, M. G., Harrell, C. R., Fellabaum, C., Djonov, V., & Arsenijevic, N. (2019). Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity. Journal of Biomedical Science, 26(1), 25.
Wolf, M., de Boer, A., Sharma, K., Boor, P., Leiner, T., Sunder-Plassmann, G., Moser, E., Caroli, A., & Jerome, N. P. (2018). Magnetic resonance imaging T1- and T2-mapping to assess renal structure and function: a systematic review and statement paper. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association, 33(suppl_2), ii41–ii50.
Gorelik, Y., Yaseen, H., Heyman, S. N., & Khamaisi, M. (2019). Negligible risk of acute renal failure among hospitalized patients after contrast-enhanced imaging with iodinated versus gadolinium-based agents. Investigative Radiology, 54(5), 312–318.
Ozkok, S., & Ozkok, A. (2017). Contrast-induced acute kidney injury: A review of practical points. World Journal of Nephrology, 6(3), 86–99
DOI: https://doi.org/10.23857/pc.v6i8.2985
Enlaces de Referencia
- Por el momento, no existen enlaces de referencia
Polo del Conocimiento
Revista Científico-Académica Multidisciplinaria
ISSN: 2550-682X
Casa Editora del Polo
Manta - Ecuador
Dirección: Ciudadela El Palmar, II Etapa, Manta - Manabí - Ecuador.
Código Postal: 130801
Teléfonos: 056051775/0991871420
Email: polodelconocimientorevista@gmail.com / director@polodelconocimiento.com
URL: https://www.polodelconocimiento.com/
